Sanjai Rao, MD: Long-Acting Injectables for Schizophrenia
Treatment adherence remains a concern in psychiatry.
Anita Clayton, MD: Women's Issues in Psychiatry
Postpartum depression rates have increased since the COVID-19 pandemic.
Michael Thase, MD: Risk Factors for Chronically Depressed Patients
Alcohol, stress, drug use, and not seeking help are all risk factors for chronic depression.
John J. Miller, MD: Guidance on Cannabis Use in Psychiatry
CBD has shown promise in treating anxiety and psychosis.
Christopher Schneck, MD: Early Interventions for Bipolar Disorder
There remains a need for better treatments for bipolar disorder when it is identified early.
Joseph Goldberg, MD: Treating Mixed Feature Depression
Mixed feature depression can be difficult to diagnose because the symptoms can be similar to other psychiatric disorders.
M. Katherine Shear, MD: Addressing Grief After a Loss
There remains a need for more research into the connection between grief and depression following a death.
Rethinking Psychiatry With Dr. Steve Levine: Episode 4
Dr. Levine talks with Dr. Lisa Harding about how clinicians can best improve patient care in psychiatry.
David Hudesman, MD: Where Drug Development is Going in IBD
Dr. David Hudesman expects drug developers to continue to target biologics for the treatment of IBD.
Jennifer Green, MD: Initiating, Accessing and Adjusting Insulin for Type 2 Diabetes
The Duke expert reviews key strategies for starting and continuing care with the pivotal glycemic control agent.
Arun Sanyal, MD: ALT Fluctuations in NAFLD
ALT fluctuations remained stable for patients with NAFLD throughout disease progression.
Educating Third-Year Students on Opioid Use Disorder, Pain Management
An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.
Rishi Kakar, MD: The Promise of LSD as a Psych Treatment
MM-120 is a pharmacologically optimized form of Lysergic acid diethylamide (LSD).
The Adequate Evaluation Teams, Treatment Plans for Stevens-Johnson Syndrome
Travis Vandergriff, MD, discusses the unique collaboration with ophthalmologists and urologists in the rare skin condition.
Carla Lamb, MD: Innovations in CT Scan Accuracy
The interventional pulmonology specialist discusses new technology and devices available for diagnosing lung cancer.
The Signs and Symptoms of Stevens-Johnson Syndrome
A dive into the manifestation of the rare skin condition, and the impactful role of dermatologists in diagnosing it early.
Matthew Budoff, MD: The Clinical Utility of Coronary Calcium Scoring
At HiD 2022, Dr. Budoff discusses the use and utility of coronary calcium scoring for risk stratification
The Pitfalls, Benefits of Influencing Dermatology Social Media
Savanna Perry, PA-C, discussed the challenge of standing out over influencers and estheticians regarding clinical dermatology insight, and the unique offerings of different platforms.
The Benefits & Challenges of Social Media Healthcare
Savanna Perry, PA-C, founder of The PA Platform, discusses the strategies and goals that go into building an online audience as a healthcare professional.
Jeffrey Cohen, MD: Addressing Depression and Anxiety in Women with Lichen Sclerosis
Dr. Cohen details the latest study from Yale, which indicated that women from lichen sclerosus had increased risk of developing depression and anxiety.
Akash B. Gadani, MD: The Importance of Diet for GERD
Dr. Gadani often suggests patients eat smaller meals and do not eat too close to bedtime.
Lisa Arkin, MD: Advancements in Scleroderma Treatment Strategies
Dr. Lisa Arkin speaks to how evidence-based, expert opinion-led consensus treatment plans for scleroderma can help change the way patients and providers approach the disease.
Kelly Cordoro, MD: Diagnosing and Treating Pediatric Scleroderma
Dr. Cordoro speaks on the prevalence of variants of scleroderma in children, and how provides can better recognize and treat the disease in pediatric populations.
Uncovering Clinical Meaning of Sleep in Early Cognitive Development
Mark Blumberg, MD, discusses his laboratory's particular interest in early REM sleep movement, and its potential impact on neurological disorders.
Sarah Bermudez, PharmD: SGLT2 Inhibitors Underutilized in Heart Failure Care
The late-breaking data show SGLT2is are underutilized in patients with heart failure with or without type 2 diabetes despite guideline recommendations.
Roy Taylor, MD: Using Personal Fat Thresholds to Reach Type 2 Diabetes Remission
The diabetologist and professor discusses new findings from the ReTUNE trial, which disparage the utility of BMI in defining diabetes risk and remission opportunity.
Adalberto Gonzalez, MD: Furthering the Safety of IBD Treatments
In recent years more and more biologics have come on the market for the treatment of IBD.
Educating Psychiatry Trainees on Social Determinants of Health
A Montefiore residency director explains the impact of engaging with communities to improve mental health care capability.
Adalberto Gonzalez, MD: The Safety of Biologics for IBD
In data presented at DDW, there was no evidence found showing biologics result in an increased risk of developing malignancies for patients with IBD and PSC.
Yoga vs Antidepressants: Defining Workplace Burnout Over Mental Health Issues
Montefiore's Carol A. Bernstein, MD, discusses the role of psychiatry specialists in discerning their colleagues' need for mental health care or resolutions to burnout.
